Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular ( CV ) Risk in People with HIV
Study Demonstrates Excess Visceral Abdominal Fat Drives CV Risk Study Demonstrates Excess Visceral Abdominal Fat Drives CV Risk ...
Here's How Much You'd Need to Put in Your 401 ( k ) to Save $1 Million in 25 Years
Saving for retirement takes decades of consistent work, but it's more important than ever to have a healthy nest egg heading into your senior years.While the amount you should aim to save by retirement age will depend on your unique circumstances, a common goal is to have a nest egg worth at ...
Emergency Medical Service Products Market to Reach USD 62 Billion by 2035, Growing at a 6.4% CAGR | Fact.MR Report
Rockville, MD, March 12, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, The global emergency medical service products market was valued at USD 31 billion in 2024 and is projected to register a noteworthy CAGR of 6.4% to end up at USD 62 billion by 2035.
Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROI
Results show similar levels of virus undetectability in patients on ibalizumab-containing regimens as in controls, despite greater baseline severity of ...
JOYY to Announce Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025 - JOYY ( NASDAQ:YY )
SINGAPORE, March 12, 2025 ( GLOBE NEWSWIRE ) -- JOYY Inc. YY ( "JOYY" or the "Company" ) , a global technology company, today announced that it plans to release its fourth quarter and full year 2024 financial results after the U.S. market closes on March 19, 2025.
Mesoblast CEO to Deliver Featured Presentation at ISCT North America Virtual Town Hall
NEW YORK, March 12, 2025 ( GLOBE NEWSWIRE ) -- Mesoblast Limited ( Nasdaq:MESO. ASX:MSB ) , global leader in allogeneic cellular medicines for inflammatory diseases, announced today that Chief Executive Silviu Itescu will deliver the Featured Presentation at the International Cell & Gene Therapy ...
Atsena Therapeutics Granted U.S. FDA Fast Track Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
DURHAM, N.C., March 12, 2025 ( GLOBE NEWSWIRE ) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S.
Compass Lexecon Adds Antitrust and Economics Expert William Rogerson
WASHINGTON, March 12, 2025 ( GLOBE NEWSWIRE ) -- FTI Consulting, Inc. ( NYSE: FCN ) today announced that Dr. William Rogerson has affiliated with its subsidiary Compass Lexecon.
Kelly to Participate in Sidoti Virtual Investor Conference
TROY, Mich., March 12, 2025 ( GLOBE NEWSWIRE ) -- Kelly ( Nasdaq: KELYA, KELYB ) , a leading global specialty talent solutions provider, today announced it will participate in the Sidoti Virtual Investor Conference on Wednesday, March 19, 2025.
American Tungsten Corp. Identifies Principal Exploration Target for the IMA Mine Project in Idaho, USA
Vancouver, BC, March 12, 2025 ( GLOBE NEWSWIRE ) -- American Tungsten Corp. ( CSE:TUNG ) ( OTCQB:DEMRF ) ( FSE:RK9 ) ( "American Tungsten" or the "Company" ) announced that it has identified a principal tungsten exploration target on the IMA Mine and is initiating planning and execution of a ...
